» Articles » PMID: 31487864

Molecular Characteristics and Treatment of Endothelial Dysfunction in Patients with COPD: A Review Article

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Sep 7
PMID 31487864
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with chronic obstructive pulmonary disease (COPD) show systemic consequences, such as chronic systemic inflammation leading to changes in the airway, airway penetrability, and endothelial function. Endothelial dysfunction is characterized by a list of alterations of endothelium towards reduced vasodilation, proinflammatory state, detachment and apoptosis of endothelial cells, and development of atherosclerosis. COPD-induced endothelial dysfunction is associated with elevated cardiovascular risk. The increment of physical activities such as pulmonary rehabilitation (PR) training have a significant effect on COPD, thus, PR can be an integrative part of COPD treatment. In this narrative review the focus is on the function of endothelial inflammatory mediators [cytokines, chemokines, and cellular proteases] and pulmonary endothelial cells and endothelial dysfunction in COPD as well as the effects of dysfunction of the endothelium may play in COPD-related pulmonary hypertension. The relationship between smoking and endothelial dysfunction is also discussed. The connection between different pulmonary rehabilitation programs, arterial stiffness and pulse wave velocity (PWV) is presented. Endothelial dysfunction is a significant prognostic factor of COPD, which can be characterized by PWV. We discuss future considerations, like training programs, as an important part of the treatment that has a favorable impact on the endothelial function.

Citing Articles

The effectiveness of vasodilators on chronic obstructive pulmonary disease: A systematic review and meta-analysis.

Han N, Qi H, Yin Y, Liu Y, Jin P, Hou Y Medicine (Baltimore). 2024; 103(46):e39794.

PMID: 39560512 PMC: 11576023. DOI: 10.1097/MD.0000000000039794.


Key role of activated platelets in the enhanced adhesion of circulating leucocyte-platelet aggregates to the dysfunctional endothelium in early-stage COPD.

Marques P, Bocigas I, Domingo E, Francisco V, Tarraso J, Garcia-Sanjuan Y Front Immunol. 2024; 15:1441637.

PMID: 39229275 PMC: 11369892. DOI: 10.3389/fimmu.2024.1441637.


The mediating effect of depression on the association between lung disease and cardiovascular health.

Chen F, Lin H, Zhang Y, Zhang Y, Yang E Arch Med Sci. 2024; 20(3):1029-1033.

PMID: 39050146 PMC: 11264099. DOI: 10.5114/aoms/189973.


Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study.

Yang H, Ryu M, Carey V, Kinney G, Hokanson J, Dransfield M J Am Heart Assoc. 2024; 13(11):e033882.

PMID: 38818936 PMC: 11255614. DOI: 10.1161/JAHA.123.033882.


scMoresDB: A comprehensive database of single-cell multi-omics data for human respiratory system.

Chen K, Han Y, Wang Y, Zhou D, Wu F, Cai W iScience. 2024; 27(4):109567.

PMID: 38617561 PMC: 11015448. DOI: 10.1016/j.isci.2024.109567.


References
1.
Henson P, Vandivier R, Douglas I . Cell death, remodeling, and repair in chronic obstructive pulmonary disease?. Proc Am Thorac Soc. 2006; 3(8):713-7. PMC: 2647658. DOI: 10.1513/pats.200605-104SF. View

2.
Bathoorn E, Liesker J, Postma D, Boorsma M, Bondesson E, Koeter G . Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. COPD. 2008; 5(5):282-90. DOI: 10.1080/15412550802363360. View

3.
Li D, Wu Y, Tian P, Zhang X, Wang H, Wang T . Adipokine CTRP-5 as a Potential Novel Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease. Medicine (Baltimore). 2015; 94(36):e1503. PMC: 4616636. DOI: 10.1097/MD.0000000000001503. View

4.
Santos S, Peinado V, Ramirez J, Morales-Blanhir J, Bastos R, Roca J . Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003; 167(9):1250-6. DOI: 10.1164/rccm.200210-1233OC. View

5.
Chhabra S, De S . Cardiovascular autonomic neuropathy in chronic obstructive pulmonary disease. Respir Med. 2005; 99(1):126-33. DOI: 10.1016/j.rmed.2004.06.003. View